Last Posted: Nov-29-2023 05:34:01

The Ethics of Using COVID-19 Host Genomic Information for Clinical and Public Health Decision-making: A Survey of US Health Professionals.
Sheethal Jose et al. HGG Adv 2023 11 100255
mRNA SARS-CoV-2 Vaccination Before vs During Pregnancy and Omicron Infection Among Infants.
Orlanda Goh et al. JAMA Netw Open 2023 11 (11) e2342475
Changes in SARS-CoV-2 Sequence Linked With Antiviral Use.
Emily Harris et al. JAMA 2023 10 (16) 1515
mRNA COVID vaccines saved lives and won a Nobel - what's next for the technology?
Elie Dolgin et al. Nature 2023 10

Tulu Thomas Wetere, et al. BMC digital health 2023 0 0. (1) 6
Application of machine learning models to identify serological predictors of COVID-19 severity and outcomes.
Klein Sabra, et al. Research square 2023 0 0.
Application of Machine Learning Prediction of Individual SARS-CoV-2 Vaccination and Infection Status to the French Serosurveillance Survey From March 2020 to 2022: Cross-Sectional Study.
Bougeard Stéphanie, et al. JMIR public health and surveillance 2023 0 0. e46898
Real-world Effectiveness of BNT162b2 Against Infection and Severe Diseases in Children and Adolescents.
Wu Qiong, et al. medRxiv : the preprint server for health sciences 2023 0 0.
Genomic analysis of SARS-CoV-2 omicron sublineage BA.5.2.1 in Erbil/Iraq.
Majed Sevan Omer, et al. Cellular and molecular biology (Noisy-le-Grand, France) 2023 0 0. (11) 56-63
Plasmonic digital PCR for discriminative detection of SARS-CoV-2 variants.
Kim Kyung Ho, et al. Biosensors & bioelectronics 2023 0 0. 115859
Single-molecule force stability of the SARS-CoV-2-ACE2 interface in variants-of-concern.
Bauer Magnus S, et al. Nature nanotechnology 2023 0 0.
A web-based genome-wide association study reveals the susceptibility loci of common adverse events following COVID-19 vaccination in the Japanese population.
Nogawa Shun, et al. Scientific reports 2023 0 0. (1) 20820
C1 esterase inhibitor-mediated immunosuppression in COVID-19: Friend or foe?
Hausburg Melissa A, et al. Clinical immunology communications 2023 0 0. 83-90
All Latest
About COVID-19 GPH
Site Citation:
Wei Yu, et al. COVID-19 GPH: tracking the contribution of genomics and precision health to the COVID-19 pandemic response. BMC Infectious Diseases (2022) 22:402.


Special Topics
In PHGKB Databases
Genomics Precision Health (GPH): The use of pathogen and human genomics and advanced molecular detection methods in discovery, clinical and public health investigations and response to COVID-19.
Non Genomics Precision Health (non-GPH): The use of big data, data science, digital health, machine learning and predictive analytic methods (not involving genomics) in discovery, clinical and public health investigations and response to COVID-19
Following categories are annotated by LitCovid from NCBI NIH.
Mechanism | Underlying cause(s) of covid-19 infections and transmission & possible drug mechanism of action |
Transmission | Characteristics and modes of covid-19 transmissions, such as human-to-human |
Diagnosis | Disease assessment through symptoms, test results, and radiological features |
Prevention | Prevention, control, response and management strategies |
Case Report | Descriptions of specific patient cases |
Forecasting | Modelling and estimating the trend of covid-19 spread |
Health Equity | Relevant to health equity. Search terms are derived from a list provided by the Association for Territorial Health Officials which include terms such as diversity, health disparities, and others. |
Vaccine | Relevant to vaccine development, evaluation, implementation and impact. For additional information on vaccines and COVID-19. Check out general CDC Information pages |
Variant | Relevant to SARS-CoV-2 variants and their impact on public health. For additional information on variants COVID-19. Check out CDC New Variants of the Virus that Causes COVID-19 page |
Surveillance | Relevant to SARS-CoV-2 public health surveillance and tracking. For additional information on COVID-19 surveillance, check out CDC COVID-19 Data Tracker |
Wei Yu, Emily Drzymalla, Marta Gwinn and Muin J. Khoury. COVID-19 GPH: tracking the contribution of genomics and precision health to the COVID-19 pandemic response. BMC Infectious Diseases (2022) 22:402.
Disclaimer: Articles listed in the Public Health Genomics and Precision Health Knowledge Base are selected by the CDC Office of Genomics and Precision Public Health to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Oct 1, 2023
- Page last updated:Nov 29, 2023
- Content source: